1 0

    FDA Adverse Event Summary for Tyvaso, Tyvaso DPI, and Korlym (Mar 2025)

    FDA Adverse Event Summary for Tyvaso, Tyvaso DPI, and Korlym (Mar 2025)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: Please provide me with data summarizing reports of adverse events associated with the following drugs between March 1, 2025 and March 19, 2025: Tyvaso and Tyvaso DPI (treprostinil) and Korlym (mifepristone).
    Tags: Pharma, Adverse Event, 2025

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details